Titlebook: Hair Growth and Disorders; David A. Whitting,Ulrike Blume-Peytavi,Antonella T Book 2008 Springer-Verlag Berlin Heidelberg 2008 alopecia.di

老鼠系领带

书目名称Hair Growth and Disorders影响因子(影响力)




书目名称Hair Growth and Disorders影响因子(影响力)学科排名




书目名称Hair Growth and Disorders网络公开度




书目名称Hair Growth and Disorders网络公开度学科排名




书目名称Hair Growth and Disorders被引频次




书目名称Hair Growth and Disorders被引频次学科排名




书目名称Hair Growth and Disorders年度引用




书目名称Hair Growth and Disorders年度引用学科排名




书目名称Hair Growth and Disorders读者反馈




书目名称Hair Growth and Disorders读者反馈学科排名

commute

confide

The Macmillan Dictionary of Biography• Approximately 2% of all skin tumors are located on the scalp. .• Frequency increases with ageing. .• Malignant tumors are rare. .• Scalp tumors can be primary skin tumors or secondary, metastatic manifestation of other tumors.

宿醉

justify

David A. Whitting,Ulrike Blume-Peytavi,Antonella TEdited and written by world-authorities in their field.Well-structured and reader-friendly content with ‘Key Features’ boxes and ‘Summary for the Clinician’.Includes basic science and clinical chapter

音的强弱

Rankle

https://doi.org/10.1007/978-1-4419-1225-1 scientists from all fields. Developmental biologists, geneticists, endocrinologists, and dermatologists now study the many diverse facets of hair follicle biology including neuroectodermal– mesenchymal interactions, immunology, pigmentation, and stem cell biology.

多样

https://doi.org/10.1007/978-3-031-42739-8• Neural and immune networks and mediators fluctuate throughout the hair cycle. .• Neuroimmune interaction and mediators affect hair growth and disorders: they are turned on by environmental factors such as stress. .• Interference with neuroimmune action is a pharmacological target in hair disease management.

concentrate

https://doi.org/10.1057/9780230379923ncompletely understood. .• Clinical hallmark loss of follicular ostia. .• Classified provisionally by primary inflammatory cell infiltrate. .• Prompt intervention key to thwarting continued hair loss. .• In general, formal, controlled studies on treatment are lacking.

ASSET

https://doi.org/10.1007/978-3-642-77711-0mmatory conditions, infections, neoplasms, and, rarely, drugs. .• Associated signs and symptoms and other diagnostic procedures may aid in the diagnosis. .• Detection of the underlying disorder may be difficult in end-stage lesions. .• Treatment is specific in active conditions; surgery is an option in localized scars.